Patrick P. Lally
Directeur/Membre du Conseil chez CorneaGen, Inc.
Profil
Patrick P.
Lally is currently a Director at CorneaGen, Inc., Aurion Biotech, Inc., and Vero Biotech, Inc. He is also a Partner at Petrichor Healthcare Capital Management LP since 2018.
Previously, he held positions as Vice President at OrbiMed Advisors LLC, Principal at Barclays Capital, Inc., Senior Analyst at Red Mountain Capital Partners LLC, and Associate at Fortress Investment Group LLC.
Lally received his undergraduate degree from Princeton University and his MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Patrick P. Lally
| Sociétés | Poste | Début |
|---|---|---|
Petrichor Healthcare Capital Management LP
 Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is an independent private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Private Equity Investor | 01/01/2018 |
Aurion Biotech, Inc.
 Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
CorneaGen, Inc.
 CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
| Vero Biotech, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Patrick P. Lally
| Sociétés | Poste | Fin |
|---|---|---|
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Corporate Officer/Principal | - |
Red Mountain Capital Partners LLC
 Red Mountain Capital Partners LLC Investment ManagersFinance Red Mountain Capital Partners LLC (Red Mountain) is an alternative asset manager headquartered in Los Angeles, California. The firm was founded in 2005 and a subsidiary of Mesdag Family LP, which is principally owned by the Mesdag Family Trust. Red Mountain provides sound strategic advice to their portfolio companies to help drive long-term sustainable shareholder value. | Corporate Officer/Principal | - |
| FORTRESS INVESTMENT GROUP LLC | Corporate Officer/Principal | - |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Portfolio Manager-Fixed Income | - |
Formation de Patrick P. Lally
| Princeton University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
Red Mountain Capital Partners LLC
Red Mountain Capital Partners LLC Investment ManagersFinance Red Mountain Capital Partners LLC (Red Mountain) is an alternative asset manager headquartered in Los Angeles, California. The firm was founded in 2005 and a subsidiary of Mesdag Family LP, which is principally owned by the Mesdag Family Trust. Red Mountain provides sound strategic advice to their portfolio companies to help drive long-term sustainable shareholder value. | Finance |
Fortress Investment Group LLC
 Fortress Investment Group LLC Investment ManagersFinance Fortress Investment Group LLC provides investment management services. It specializes in asset-based investment, operations management, mergers and acquisitions, and capital markets. The company was founded by Wesley Robert Edens, Robert I. Kauffman, and Randal Alan Nardone in 1998 and is headquartered in New York, NY. | Finance |
CorneaGen, Inc.
CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA. | Health Technology |
Petrichor Healthcare Capital Management LP
Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is an independent private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Finance |
Aurion Biotech, Inc.
Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | Health Services |
| Vero Biotech, Inc. |